An energy boost following her breakup with coffee reminds columnist Susan Payrovi, MD. to focus on clean, renewable sources of energy.

Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study finds.

Having parents with a history of smoking is associated with a significantly increased risk of developing pediatric MS, a ...

For years, columnist Ben Hofmeister avoided talking about his invisible scars caused by the silent challenges of life with MS.